Literature DB >> 23180867

Explaining the decline in coronary heart disease mortality in the Czech Republic between 1985 and 2007.

Jan Bruthans1, Renata Cífková2, Věra Lánská3, Martin O'Flaherty4, Julia A Critchley5, Jiří Holub6, Petr Janský7, Jana Zvárová8, Simon Capewell4.   

Abstract

BACKGROUND: Coronary heart disease (CHD) mortality has declined substantially in the Czech Republic over the last two decades.
DESIGN: The purpose of this study was to determine what proportion of this CHD mortality decline could be associated with temporal trends in major CHD risk factors and what proportion with advances in medical and surgical treatments.
METHODS: The validated IMPACT mortality model was used to combine and analyse data on uptake and effectiveness of CHD management and risk factor trends in the Czech Republic in adults aged 25-74 years between 1985 and 2007. The main sources were official statistics, national quality of care registries, published trials and meta-analyses, and the Czech MONICA and Czech post-MONICA studies.
RESULTS: Between 1985 and 2007, age-adjusted CHD mortality rates in the Czech Republic decreased by 66.2% in men and 65.4% in women in the age group 25-74 years, representing 12,080 fewer CHD deaths in 2007. Changes in CHD risk factors explained approximately 52% of the total mortality decrease, and improvements in medical treatments approximately 43%. Increases in body mass index and in diabetes prevalence had a negative impact, increasing CHD mortality by approximately 1% and 5%, respectively.
CONCLUSIONS: More than half of the very substantial fall in CHD mortality in the Czech Republic between 1985 and 2007 was attributable to reduction in major cardiovascular risk factors. Improvement in treatments accounted for approximately 43% of the total mortality decrease. These findings emphasize the value of primary prevention and evidence-based medical treatment. © The European Society of Cardiology 2012.

Entities:  

Keywords:  Coronary heart disease; Czech MONICA and Czech post-MONICA; coronary heart disease management; coronary heart disease mortality; coronary heart disease risk factors

Mesh:

Year:  2012        PMID: 23180867     DOI: 10.1177/2047487312469476

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


  15 in total

Review 1.  Decline in Cardiovascular Mortality: Possible Causes and Implications.

Authors:  George A Mensah; Gina S Wei; Paul D Sorlie; Lawrence J Fine; Yves Rosenberg; Peter G Kaufmann; Michael E Mussolino; Lucy L Hsu; Ebyan Addou; Michael M Engelgau; David Gordon
Journal:  Circ Res       Date:  2017-01-20       Impact factor: 17.367

2.  The prognosis and therapeutic management of patients hospitalized for heart failure in 2010-2020.

Authors:  Otto Mayer; Jan Bruthans; Simona Bilkova; Jitka Seidlerova; Josef Jirak; Jan Filipovsky
Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub       Date:  2022-04-20       Impact factor: 1.648

Review 3.  Implications of the growing burden of diabetes for premature cardiovascular disease mortality and the attainment of the Sustainable Development Goal target 3.4.

Authors:  Constance Wou; Nigel Unwin; Yadi Huang; Gojka Roglic
Journal:  Cardiovasc Diagn Ther       Date:  2019-04

4.  Does inclusion of education and marital status improve SCORE performance in central and eastern europe and former soviet union? findings from MONICA and HAPIEE cohorts.

Authors:  Olga Vikhireva; Grazyna Broda; Ruzena Kubinova; Sofia Malyutina; Andrzej Pająk; Abdonas Tamosiunas; Zdena Skodova; Galina Simonova; Martin Bobak; Hynek Pikhart
Journal:  PLoS One       Date:  2014-04-08       Impact factor: 3.240

5.  A higher burden of metabolic risk factors and underutilization of therapy among women compared to men might influence a poorer prognosis: a study among acute myocardial patients in Albania, a transitional country in Southeastern Europe.

Authors:  Sokol Myftiu; Enxhela Sulo; Genc Burazeri; Ilir Sharka; Artan Shkoza; Gerhard Sulo
Journal:  Croat Med J       Date:  2015-12       Impact factor: 1.351

6.  Explaining the Decline in Coronary Heart Disease Mortality in the Netherlands between 1997 and 2007.

Authors:  Carla Koopman; Ilonca Vaartjes; Ineke van Dis; W M Monique Verschuren; Peter Engelfriet; Edith M Heintjes; Anneke Blokstra; Dorly J H Deeg; Marjolein Visser; Michiel L Bots; Martin O'Flaherty; Simon Capewell
Journal:  PLoS One       Date:  2016-12-01       Impact factor: 3.240

7.  Current and past smoking patterns in a Central European urban population: a cross-sectional study in a high-burden country.

Authors:  Narine K Movsisyan; Ondrej Sochor; Eva Kralikova; Renata Cifkova; Hana Ross; Francisco Lopez-Jimenez
Journal:  BMC Public Health       Date:  2016-07-15       Impact factor: 3.295

8.  Explaining the decline in coronary heart disease mortality rates in the Slovak Republic between 1993-2008.

Authors:  Marek Psota; Piotr Bandosz; Eva Gonçalvesová; Mária Avdičová; Mária Bucek Pšenková; Martin Studenčan; Jarmila Pekarčíková; Simon Capewell; Martin O'Flaherty
Journal:  PLoS One       Date:  2018-01-10       Impact factor: 3.240

9.  Population assessment of future trajectories in coronary heart disease mortality.

Authors:  Rosa Björk Thorolfsdottir; Thor Aspelund; Simon Capewell; Julia Critchley; Vilmundur Gudnason; Karl Andersen
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

10.  Exploring potential mortality reductions in 9 European countries by improving diet and lifestyle: A modelling approach.

Authors:  M O'Flaherty; P Bandosz; J Critchley; S Capewell; M Guzman-Castillo; T Aspelund; K Bennett; K Kabir; L Björck; J Bruthans; J W Hotchkiss; J Hughes; T Laatikainen; L Palmieri; T Zdrojewski
Journal:  Int J Cardiol       Date:  2016-01-11       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.